ANTHONY P. ADAMIS - 23 Jun 2022 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Issuer symbol
EYPT
Transactions as of
23 Jun 2022
Net transactions value
$0
Form type
4
Filing time
27 Jun 2022, 16:38:27 UTC
Next filing
22 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Restricted Stock Units Award $0 +6,000 $0.000000 6,000 23 Jun 2022 Common Stock 6,000 $0.000000 Direct F1
transaction EYPT Stock Option (Right to Buy) Award $0 +22,000 $0.000000 22,000 23 Jun 2022 Common Stock 22,000 $7.54 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units will vest in three equal annual installments beginning June 23, 2023.
F2 The option becomes exercisable in three ratable annual installments beginning on June 23, 2023.